Steven Cohen Verona Pharma PLC Transaction History
Point72 Asset Management, L.P.
- $39.3 Billion
- Q1 2024
Shares
2 transactions
Others Institutions Holding VRNA
# of Institutions
115Shares Held
60.7MCall Options Held
139KPut Options Held
67.8K-
Nea Management Company, LLC Timonium, MD5.11MShares$73.9 Million5.77% of portfolio
-
Wellington Management Group LLP Boston, MA3.91MShares$56.5 Million0.01% of portfolio
-
Perceptive Advisors LLC New York, NY3.76MShares$54.4 Million1.27% of portfolio
-
Vivo Capital, LLC Palo Alto, CA3.61MShares$52.2 Million7.77% of portfolio
-
Orbimed Advisors LLC San Diego, CA3.4MShares$49.1 Million1.23% of portfolio
About Verona Pharma plc
- Ticker VRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,954,200
- Market Cap $881M
- Description
- Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...